Production & Manufacturing
Press Releases
J&J collaboration to expand manufacturing capabilities for its COVID-19 vaccine candidate manufacturing
Johnson & Johnson announced a collaboration between the Janssen Pharmaceutical Companies of Johnson & Johnson and Emergent BioSolutions, Inc. to support the manufacturing of its lead investigational COVID-19 vaccine candidate. This is the first in a series of prospective...
News
GSK allies with Innovax for COVID-19 vaccine R&D project
GlaxoSmithKline has teamed up with Xiamen Innovax Biotech to evaluate a vaccine against the novel coronavirus behind the COVID-19 pandemic. The agreement gives Innovax access to a GSK adjuvant to enhance the immune response triggered by its recombinant protein-based...
News
Gilead ramps up production of experimental Covid-19 treatment amid criticism over access
Gilead Sciences has been ramping up production of its experimental remdesivir treatment that is being tested to combat the novel coronavirus.
The drug maker now has 1.5 million individual dosages that could be used for more than 140,000 patients and...
Press Releases
Sense, Phillips-Medisize partner to speed up production of new COVID-19 test
Sense has announced an accelerated programme to launch the world’s first instrument-free, point-of-care molecular diagnostic test for SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic.
Sense is partnering closely with Phillips-Medisize, a Molex company and leading global medical device innovator,...
Drug Research
Univercells launches cell & gene therapy CMDO Exothera with GMP capabilities in 15,000m2 site in Jumet, Belgium
Univercells has launched a contract development and manufacturing organization (CDMO), Exothera, to support cell and gene therapy developers with process development and production of viral vectors. The company has been created to help alleviate the two most critical challenges...
Press Releases
CDMO to invest over €3m in GMP facility expansion
Spray drying specialist and capsule filling service provider Micro-Sphere is investing 3.5 million CHF (€3.2 million) into expanding its GMP manufacturing capabilities and processes.
Micro-Sphere will add an additional spray drying line to its facility in Switzerland in response to...
Press Releases
Sterling Pharma Solutions invests $1.5m into US facility expansion
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, is investing $1.5m into a phased expansion of its US facility in North Carolina.
The investment follows the acquisition of the former US CiVentiChem site earlier this year. Over the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read